跳至主要内容
临床试验/NCT01914458
NCT01914458Unknown2 期

Low-Dose Computed Tomography for Lung Cancer Screening in High Risk Asymptomatic Patients: the Taiwan Study

Cathay General Hospital2 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2013年2月最近更新:
适应症
干预措施

试验速览

阶段
2 期
入组人数
600
试验地点
2
主要终点
Lung cancer detection rate

研究概览

简要总结

Lung cancer is the leading cause of cancer related death in Taiwan and world wide. The application of low dose helical computed tomography (CT) has been the milestone of lung cancer screening. Recently, The National Lung Screening Trial (NLST) shows screening with low-dose CT could reduce mortality from lung cancer. We conducted this clinical trial to determine the efficacy of low dose CT in early lung cancer screening in Taiwan.

详细描述

This is a single center, single arm, non-randomized prospective study. We plan to enroll persons between 50 and 74 years in age, who had cigarette smoking of at least 30 pack-years, and, if former smokers, had quit within the previous 15 years. Persons who had previously received a diagnosis of lung cancer, had undergone chest CT within 18 months before enrollment, had hemoptysis, or had an unexplained weight loss of more than 6.8 kg in the preceding year were excluded.

All the participants should complete a questionnaire that covers many topics, including demographic characteristics and smoking behavior. We also plan to collect additional data for planned analyses of cost-effectiveness, and smoking cessation. Lung-cancer got by biopsy and other biospecimens are available to researchers through a peer-review process All screening examinations are planed to perform in accordance with a standard protocol, developed by medical physicists associated with the trial, that specified acceptable characteristics of the machine and acquisition variables. All low-dose CT scans are acquired with the use of multidetector scanners with a minimum of 16 channels.

IDEALCAP radiologists are certified by appropriate agencies or boards and has completed training in image acquisition; radiologists also has completed training in image quality and standardized image interpretation. Images are interpreted first in isolation and then in comparison with available historical images and images from prior IDEALCAP screening examinations.

IDEALCAP primary analysis is the detection rate of lung cancer. Secondary analysis include the detection rate of lung nodule, 5-year survival rate of persons with lung cancer who receive standard surgical treatment, 5-year survival rate of persons with lung cancer who receive alternative treatment other than standard surgical treatment (ex. Radiotherapy, chemotherapy or target therapy), the correlation of CT images and cigarette smoking history, the correlation of CT images and pulmonary function.

Key Word: low dose computed-tomography (LDCT), lung cancer screening

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
50 Years 至 74 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 50-74 years
  • 30 or more pack-years of cigarette smoking history
  • Former smokers: quit smoking within the previous 15 years
  • Ability to tolerate CT procedure
  • Signed informed consent

排除标准

  • Severe uncontrolled heart, vascular, respiratory or endocrine pathology.
  • Life-expectancy less than 1 year
  • History of lung cancer
  • Acute respiratory disease
  • Hemoptysis.
  • Weight loss more than 6.8 kg in the 12 months prior to eligibility assessment
  • Participation in other cancer clinical trial
  • Chest CT examination in the 12 months prior to eligibility assessment.

研究组 & 干预措施

Low-dose computed tomography (LDCT)

Experimental

Patients will have one baseline LDCT scan.

干预措施: Low-dose computed tomography (LDCT) (Procedure)

结局指标

主要结局

Lung cancer detection rate

时间窗: 2 years

Assess number of lung cancer diagnoses after radiological and morphological verification of positive lung nodules.

次要结局

  • All-cause mortality(5 years)
  • Smoking cessation rate(one year)
  • Nodule detection rate(3 months)
  • Lung cancer mortality(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Cathay General Hosp. IRB

CGHIRB

Cathay General Hospital

研究点 (2)

Loading locations...

相似试验